Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
16360 | 593 | 32.7 | 75% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
361 | 16717 | ACINETOBACTER BAUMANNII//ESBL//EXTENDED SPECTRUM BETA LACTAMASE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CEFTAROLINE | Author keyword | 58 | 73% | 8% | 45 |
2 | CEFTOBIPROLE | Author keyword | 35 | 64% | 6% | 34 |
3 | CEFTOLOZANE TAZOBACTAM | Author keyword | 21 | 90% | 2% | 9 |
4 | AVIBACTAM | Author keyword | 19 | 80% | 2% | 12 |
5 | CEFTAROLINE FOSAMIL | Author keyword | 12 | 63% | 2% | 12 |
6 | CEFTAZIDIME AVIBACTAM | Author keyword | 12 | 86% | 1% | 6 |
7 | BAL9141 | Author keyword | 6 | 80% | 1% | 4 |
8 | ANTIINFECT CHEM | Address | 5 | 63% | 1% | 5 |
9 | FR264205 | Author keyword | 4 | 75% | 1% | 3 |
10 | NXL104 | Author keyword | 4 | 75% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CEFTAROLINE | 58 | 73% | 8% | 45 | Search CEFTAROLINE | Search CEFTAROLINE |
2 | CEFTOBIPROLE | 35 | 64% | 6% | 34 | Search CEFTOBIPROLE | Search CEFTOBIPROLE |
3 | CEFTOLOZANE TAZOBACTAM | 21 | 90% | 2% | 9 | Search CEFTOLOZANE+TAZOBACTAM | Search CEFTOLOZANE+TAZOBACTAM |
4 | AVIBACTAM | 19 | 80% | 2% | 12 | Search AVIBACTAM | Search AVIBACTAM |
5 | CEFTAROLINE FOSAMIL | 12 | 63% | 2% | 12 | Search CEFTAROLINE+FOSAMIL | Search CEFTAROLINE+FOSAMIL |
6 | CEFTAZIDIME AVIBACTAM | 12 | 86% | 1% | 6 | Search CEFTAZIDIME+AVIBACTAM | Search CEFTAZIDIME+AVIBACTAM |
7 | BAL9141 | 6 | 80% | 1% | 4 | Search BAL9141 | Search BAL9141 |
8 | FR264205 | 4 | 75% | 1% | 3 | Search FR264205 | Search FR264205 |
9 | NXL104 | 4 | 75% | 1% | 3 | Search NXL104 | Search NXL104 |
10 | COMMUNITY ACQUIRED BACTERIAL PNEUMONIA | 3 | 50% | 1% | 5 | Search COMMUNITY+ACQUIRED+BACTERIAL+PNEUMONIA | Search COMMUNITY+ACQUIRED+BACTERIAL+PNEUMONIA |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NXL104 | 69 | 91% | 5% | 29 |
2 | NXL104 COMBINATIONS | 42 | 94% | 3% | 15 |
3 | KPC CARBAPENEMASES | 41 | 90% | 3% | 18 |
4 | FOSAMIL | 41 | 81% | 4% | 25 |
5 | BAL9141 | 41 | 87% | 3% | 20 |
6 | T 91825 | 35 | 86% | 3% | 18 |
7 | BROAD SPECTRUM CEPHALOSPORIN | 32 | 36% | 12% | 73 |
8 | PPI 0903M | 32 | 88% | 3% | 15 |
9 | CXA 101 FR264205 | 27 | 92% | 2% | 11 |
10 | CANVAS 1 | 26 | 80% | 3% | 16 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Ceftolozane/Tazobactam: A Novel Cephalosporin/beta-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli | 2014 | 15 | 41 | 68% |
Ceftaroline: A Novel Cephalosporin with Activity against Methicillin-resistant Staphylococcus aureus | 2011 | 53 | 21 | 81% |
New beta-Lactamase Inhibitors: a Therapeutic Renaissance in an MDR World | 2014 | 22 | 103 | 34% |
beta-Lactam/beta-Lactamase Inhibitor Combinations: From Then to Now | 2015 | 4 | 81 | 28% |
Pharmacokinetics. and pharmacodynamics of ceftobiprole, an anti-MRSA cephalosporin with broad-spectrum activity | 2008 | 36 | 15 | 87% |
Ceftaroline A Novel Broad-Spectrum Cephalosporin with Activity against Meticillin-Resistant Staphylococcus aureus | 2009 | 38 | 26 | 54% |
Anti-MRSA beta-lactams in development, with a focus on ceftobiprole: the first anti-MRSA beta-lactam to demonstrate clinical efficacy | 2007 | 44 | 34 | 74% |
New antibiotics for bad bugs: where are we? | 2013 | 50 | 95 | 31% |
Ceftazidime-Avibactam: a Novel Cephalosporin/beta-lactamase Inhibitor Combination | 2013 | 37 | 45 | 38% |
Ceftaroline Fosamil: A Cephalosporin With Activity Against Methicillin-Resistant Staphylococcus Aureus | 2012 | 14 | 49 | 67% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANTIINFECT CHEM | 5 | 63% | 0.8% | 5 |
2 | MED THER EUT CLIN EXPT INFECT | 1 | 40% | 0.3% | 2 |
3 | BEAVER KREEK 345 | 1 | 14% | 1.0% | 6 |
4 | FIDSA | 1 | 33% | 0.3% | 2 |
5 | CIP ENZYMOL | 1 | 50% | 0.2% | 1 |
6 | HLTH SCI MS673 | 1 | 50% | 0.2% | 1 |
7 | INFECT DI ANNING | 1 | 50% | 0.2% | 1 |
8 | INFECT DISBRIGHAM WOMENS HOSP | 1 | 50% | 0.2% | 1 |
9 | MS MICROBIOL 673 | 1 | 50% | 0.2% | 1 |
10 | PHARMACOTHERPEUT | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000211283 | DAPTOMYCIN//TELAVANCIN//HVISA |
2 | 0.0000117012 | TIGECYCLINE//GLYCYLCYCLINE//GLYCYLCYCLINES |
3 | 0.0000107681 | MECA GENE//MECA//METHICILLIN RESISTANCE |
4 | 0.0000106834 | CARBAPENEMASE//OXA 48//KPC |
5 | 0.0000105512 | BETA LACTAMASE//INGN PROT//DD PEPTIDASE |
6 | 0.0000104423 | BURNS TRAUMA CRIT CARE//MUTANT SELECTION WINDOW//ANTIINFECT DEV |
7 | 0.0000093769 | LINEZOLID//OXAZOLIDINONE//LINEZOLID RESISTANCE |
8 | 0.0000087805 | METALLO BETA LACTAMASE//METALLO BETA LACTAMASES//VIM 2 |
9 | 0.0000078575 | AS 924//ORAL CEPHALOSPORIN//CEFCAPENE PIVOXIL |
10 | 0.0000077194 | DORIPENEM//ERTAPENEM//MEROPENEM |